The invention relates generally to catheters and more particularly to catheter assemblies that provide stabilization within a subintimal space of a vessel wall.
Cardiovascular disease, including atherosclerosis, is the leading cause of death in the United States. One method for treating atherosclerosis and other forms of arterial lumen narrowing is percutaneous transluminal angioplasty, commonly referred to as “angioplasty” or “PTA,” or “PTCA” when performed in the coronary arteries. The objective in angioplasty is to restore adequate blood flow through the affected artery, which may be accomplished by inflating a balloon of a balloon catheter within the narrowed lumen of the artery to dilate the vessel.
The anatomy of arteries varies widely from patient to patient. Often patient's arteries are irregularly shaped, highly tortuous and very narrow. The tortuous configuration of the arteries may present difficulties to a clinician in advancement of the balloon catheter to a treatment site. In addition, in some instances, the extent to which the lumen is narrowed at the treatment site is so severe that the lumen is completely or nearly completely obstructed, which may be described as a total occlusion. Total or near-total occlusions in arteries can prevent all or nearly all of the blood flow through the affected arteries. If the total or near total occlusion has been established for a long period of time, the lesion may be referred to as a chronic total occlusion or CTO. Chronic total occlusions can occur in coronary as well as peripheral arteries. Chronic total occlusions are often characterized by extensive plaque formation and typically include a fibrous cap surrounding softer plaque material. This fibrous cap may present a surface that is difficult to penetrate with a conventional medical guidewire.
A number of devices have been developed and/or used for the percutaneous interventional treatment of CTOs, such as stiffer guidewires, low-profile balloons, laser light emitting wires, atherectomy devices, drills, drug eluting stents, and re-entry catheters. The factor that is most determinative of whether the physician can successfully recanalize a CTO is the physician's ability to advance a suitable guidewire from a position within the true lumen of the artery that is proximal to the CTO lesion, across the CTO lesion, i.e., either through the lesion or around it, and then back into the true lumen of the artery at a location that is distal to the CTO lesion.
In some cases, such as where the artery is totally occluded by hard, calcified atherosclerotic plaque, the guidewire may tend to deviate to one side and penetrate through the intima of the artery, thereby creating a neo-lumen called a “subintimal space,” i.e., a penetration space or tract formed within the wall of the artery between the intima and adventitia. In these cases, the distal end of the guidewire may be advanced to a position distal to the lesion but remains trapped within the subintimal tract. In such instances, it is then necessary to direct or steer the guidewire from the subintimal tract back into the true lumen of the artery at a location distal to the CTO lesion. The process of manipulating the guidewire to reenter the artery lumen is often difficult and various solutions have been proposed utilizing means for handling such a presentation.
For example, a number of catheter-based devices have been suggested for redirecting subintimally placed guidewires or other medical devices back into the true lumen of the artery. Included among these are a variety of catheters having laterally deployable elements i.e., pre-shaped needles or puncturing stylets. For example, a catheter system may utilize a penetrator or needle that exits through a side exit port of the catheter to puncture the intimal layer distal of the CTO to re-enter the true lumen of the vessel. A second guidewire is then passed through the laterally deployed needle and is advanced into the true lumen of the artery. In cases in which deployable elements such as pre-shaped needles or puncturing stylets are used, their efficacy is enhanced by the stability of the catheter system inside the subintimal space. In order to provide greater stability to the catheter system, an inflatable balloon may be utilized to anchor the system inside the subintimal space. A need in the art still exists for other medical devices or systems that consistently and reliably anchor a catheter system inside the subintimal space to enhance stability of the catheter system either before or after the deployment of the puncturing element.
Embodiments hereof are directed to a catheter assembly including an outer shaft including an inflatable balloon disposed at a distal end thereof and an inner shaft including a self-expanding support structure mounted on a distal end thereof. The inner shaft is disposed within a lumen of the outer shaft such that the inner shaft is movable relative to the outer shaft. In a first configuration, the support structure is held in a radially compressed state within the outer shaft. In a second configuration, the support structure is permitted to return to an expanded state within the inflatable balloon such that the inflatable balloon has a flattened laterally-extending profile dictated by the support structure in the expanded state for anchoring the catheter assembly within the subintimal space.
Another embodiment hereof is directed to a catheter assembly that provides stabilization within a subintimal space including a stabilization mechanism disposed at a distal end of the catheter assembly. The stabilization mechanism includes a self-expanding support structure that is selectively positionable within an inflatable balloon. When the support structure is positioned within the balloon, the support structure returns to an expanded state and causes the balloon to have a flattened laterally-extending profile that corresponds to the geometry of the support structure therein for anchoring the catheter assembly within the subintimal space.
Embodiments hereof also relate to a method of stabilizing a catheter assembly within a subintimal space. In one such method, a distal end of the catheter assembly is tracked to a treatment site within the subintimal space with a self-expanding support structure held in a compressed state therein. The support structure is positioned within an inflatable balloon of the catheter assembly to permit the support structure to return to an expanded state within the balloon. The balloon is inflated around the support structure, wherein an inflated profile of the balloon corresponds to the geometry of the support structure therein.
The foregoing and other features and advantages of the invention will be apparent from the following description of embodiments hereof as illustrated in the accompanying drawings. The accompanying drawings, which are incorporated herein and form a part of the specification, further serve to explain the principles of the invention and to enable a person skilled in the pertinent art to make and use the invention. The drawings are not to scale.
Specific embodiments of the present invention are now described with reference to the figures, wherein like reference numbers indicate identical or functionally similar elements. The terms “distal” and “proximal” are used in the following description with respect to a position or direction relative to the treating clinician. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician. The term “shape memory” is used in the following description with reference to a self-expanding support structure and is intended to convey that the structure is shaped or formed from a material that can be provided with a mechanical memory to return the structure from a straightened or compressed delivery state to an expanded or deployed state. Non-exhaustive exemplary materials that may be imparted with a shape memory include stainless steel, a pseudo-elastic metal such as a nickel titanium alloy or nitinol, a so-called super alloy, which may have a base metal of nickel, cobalt, chromium, or other metal, or a polymer having a shape memory such as but not limited to polyetheretherketone (PEEK). Shape memory may be imparted to a support structure by thermal treatment to achieve a spring temper in stainless steel, for example, or to set a mechanical memory in a susceptible metal alloy, such as nitinol.
The following detailed description is merely exemplary in nature and is not intended to limit the invention or the application and uses of the invention. Although the description of the invention is in the context of treatment of blood vessels such as peripheral or coronary arteries, the invention may also be used in any other body passageways where it is deemed useful. Further, although the description of the invention generally refers to a catheter assembly and method of bypassing a vessel blockage in a proximal-to-distal direction, i.e. antegrade or with the blood flow, the invention may be used equally well to bypass a vessel blockage in a distal-to-proximal direction, i.e. retrograde or against the blood flow if access is available from that direction. In other terms, the assembly and method described herein may be considered to bypass a vessel blockage from a near side of the blockage to a far side of the blockage. Additionally, the catheter assembly may be used for stabilization within a subintimal space in other procedures or methods and is not limited to methods of bypassing an occlusion. There is no intention to be bound by any expressed or implied theory presented in the preceding technical field, background, brief summary or the following detailed description.
Embodiments hereof relate to a catheter assembly 100 having a stabilization mechanism 122 for stabilizing or anchoring the catheter assembly within a subintimal space. Stabilization mechanism 122 includes a self-expanding support structure 130 that is slidably positionable within an inflatable balloon 124. Catheter assembly 100 includes an outer shaft 102 having inflatable balloon 124 at a distal end thereof and an inner shaft 114 having self-expanding support structure 130 mounted on a distal end portion thereof. Inner shaft 114 is slidably disposed within a continuous lumen 108 that is defined within outer shaft 102 from a proximal end 104 to a distal end 106 thereof.
In a first or delivery configuration of stabilization mechanism 122 shown in
Inner shaft 114 is an elongate tubular or cylindrical element that is configured to be slidably disposed within lumen 108 of outer shaft 102. As used herein, “slidably” denotes back and forth movement in a longitudinal direction along a longitudinal axis LA of the catheter assembly 100. Inner shaft 114 defines at least one lumen 120 that extends from a proximal end 116 to a distal end 118 thereof. Proximal end 116 of inner shaft 114 is coupled to a first hub 150 having a proximal port 152 with a hemostatic valve. In an embodiment, lumen 120 may be sized to slidingly accommodate a guidewire 156 so that catheter assembly 100 is trackable over guidewire 156. Guidewire 156 is an elongate substantially straight tubular or cylindrical element that is configured to be slidably disposed within lumen 120 of inner shaft 114 and removable therefrom. Beyond distal end 118 of inner shaft 114, guidewire 156 extends through lumen 108 of outer shaft 102 such that the guidewire 156 extends through the entire length of the catheter assembly. In an embodiment, catheter assembly 100 may be sized to be used with a 6 F introducer sheath with lumen 120 of inner shaft 114 being sized to accommodate a guidewire having an outer diameter of 0.035 inch. Alternatively, catheter assembly 100 may be sized to be used with a 5 F introducer sheath with lumen 120 of inner shaft 114 being sized to accommodate a guidewire having an outer diameter of 0.018 inch. Although catheter assembly 100 is shown in
Support structure 130 is formed to have a shape memory to resume a shape set laterally expanded state as shown in
As will be discussed in more detail herein, in order to control or dictate the shape of stabilization mechanism 122, support structure 130 is formed from a generally stiffer material than balloon 124 so that balloon 124 conforms to the shape of support structure 130. Suitable materials for self-expanding support structure 130 include but are not limited to shape memory materials such as nitinol, other super-elastic alloys, and shape-memory polymers. Self-expanding support structure 130 may also be formed from metallic materials such as stainless steel.
The proximal end 104 of outer shaft 102 extends out of the patient and is coupled to a second hub 140. Proximal end 104 of outer shaft 102 is disposed within a strain relief element 154 that is attached to distally extend from second hub 140. Second hub 140 includes a proximal port 144 with a hemostatic valve to accommodate insertion of other components of catheter assembly 100 into lumen 108 of outer shaft 102. An inflation shaft or tube 110 defining an inflation lumen 112 extends through lumen 108 of outer shaft 102 to allow inflation fluid received through a Luer fitting 142 of hub 140 to be delivered to balloon 124. It will be understood by one of ordinary skill in the art that Luer fitting 142, or some other type of fitting, may be connected to a source of inflation fluid (not shown) and may be of another construction or configuration without departing from the scope of the present invention. Other types of construction are also suitable for outer shaft 102, such as, without limitation thereto, a catheter shaft having a working lumen and an inflation lumen formed by multi-lumen profile extrusion. In another embodiment hereof, discussed in more detail with respect to the embodiment of
In the embodiment of
Sealing members 127, 129 are disposed internally of outer shaft 102, radially externally of inner shaft 114 and adjacent to proximal and distal balloon ends 126, 128, respectively, for preventing leakage of inflation fluid. Sealing members 127, 129 fill or close the annular space between outer shaft 102 and inner shaft 114, thereby sealing or preventing leakage of inflation fluid that is delivered to balloon 124 for expansion thereof. More particularly, inflation fluid is delivered to balloon 124 via inflation tube 110, which extends through a wall of proximal sealing member 127 and extends just beyond or distal to proximal end 126 of balloon 124 and sealing member 127. Sealing members 127, 129 are valve-like or wiper seals that allow sliding or longitudinal movement of inner shaft 114 within outer shaft 102 while preventing leakage of the inflation fluid used for inflating balloon 124. For examples, sealing members 127, 129 are commercially available from Merit Medical Systems, Inc. of South Jordan, Utah, Qosina Corp. of Edgewood, N.Y., or Minivalve International B.V. of Oldenzaal, Netherlands. Sealing members 127, 129 may be moulded, welded, coupled via adhesive, or otherwise attached to an inner surface of outer shaft 102 such that the sealing members are integral with the outer shaft.
Deployment of catheter assembly 100 and stabilization mechanism 122 will now be discussed in more detail with reference to
After support structure 130 is laterally expanded within balloon 124, balloon 124 is then inflated at a low pressure, e.g. in the range from about 2 and 5 bar. As previously stated, balloon 124 has a cylindrical or tubular profile, and thus without support structure 130 positioned therein, cylindrical balloon 124 would inflate to a substantially cylindrical shape having a circular cross-section as shown in
When inflated around the expanded support structure 130, balloon 124 is atraumatic and expands into contact with the surrounding patient's anatomy to fill out or occupy the target anatomical space to improve anchoring as well as minimize damage to the surrounding anatomy since it is the balloon that comes into contact with the vessel wall and not the metallic wings of the support structure 130. Balloon 124 serves to provide stabilization mechanism 122 with a smooth, rounded and stable profile while maintaining the laterally extended shape of expanded support structure 130. Stated another way, laterally expanded support structure 130 dictates the overall flattened or pancake-like shape or profile of inflated balloon 124, as well as the overall lateral and longitudinally-extending shape or profile of stabilization mechanism 122. As used herein, “profile” refers to a shape of the balloon or stabilization mechanism in a top view as seen in
When positioned in target anatomy such as a subintimal space, stabilization mechanism 122 conforms to the shape of the native anatomy due to the flexible and/or compliant material characteristics thereof. The flattened, laterally-extending profile is required to conform to the shape of the target anatomical space while avoiding over-expansion of the patient's anatomy. More particularly,
Once anchoring within the target anatomy is no longer desired, stabilization mechanism 122 may be retrieved for storage and subsequent use, or for removal of catheter assembly 100. When it is desired to retrieve stabilization mechanism 122, balloon 124 is deflated and then outer shaft 102 and inner shaft 114 are moved relative to each other in order to return support structure 130 to the position of
As previously explained, due to the material thereof, support structure 130 is sufficiently compliant or flexible to conform to the shape of the target anatomical space after deployment. However, in addition to exploiting the material properties of the support structure, the support structure may also include thinned or weakened areas or joints that increase flexibility of the support structure wings at predetermined locations. For example, with respect to
In addition to openings 960, catheter assembly 900 also illustrates another embodiment of the inflation lumen. More particularly, as best shown in the enlarged perspective view of
As previously mentioned, catheter assemblies according to embodiments hereof may be utilized in a method for re-entering the true lumen of a vessel after subintimally bypassing an occlusion in a blood vessel such as a chronic total occlusion (CTO) of an artery.
As shown in
Alternatively, another device other than guidewire 156 may be initially used to create the subintimal tract. Those of ordinary skill in the art will appreciate and understand the types of alternative devices that may be used in this step including an apparatus known as an “olive”, a laser wire, an elongate radiofrequency electrode, a microcatheter, or any other device suitable for boring or advancing through the vessel tissue. If an alternative device is used instead of guidewire 156 to form the subintimal tract, such alternative device may be removed and replaced with guidewire 156 or a smaller diameter guidewire after the subintimal tract has been formed.
After the subintimal space or tract is formed, catheter assembly 100 is tracked over guidewire 156 and advanced until distal end 106 of outer shaft 102 is disposed at the far end of occlusion O as shown in
Balloon 124 is then inflated around support structure 130, as shown in
Guidewire 156 may then be proximally retracted and removed, with stabilization mechanism 122 of catheter 100 deployed as shown in
During advancement or loading of needle component 1974 through inner shaft 114, angled distal tip segment 1976 of needle component 1974 is restrained or held in a straightened state within catheter assembly 100. The combination of the inner and outer shafts of catheter assembly 100 provide sufficient rigidity to maintain angled distal tip segment 1976 of needle component 1974 in a straightened state during loading and advancement thereof. When released from catheter assembly 100, angled distal tip segment 1976 resumes its shape memory geometry by its own internal restoring forces. Thus, needle component 1974 is advanced within inner shaft 114 until angled distal tip segment 1976 extends from or protrudes out of the distal end of outer shaft 102. The distal tip segment 1976 of needle component 1974 is then oriented such that subsequent distal advancement relative to catheter assembly 100 will cause the distal tip 1980 to penetrate through the intima and thereafter gain access to the true lumen of the vessel distal to, i.e., downstream of, the CTO as shown in
A second guidewire 2082 may be advanced through a lumen (not shown) of needle component 1974 and into the true lumen TL of vessel V as shown in
In one embodiment, at this stage of bypassing a CTO, catheter assembly 100 may be removed and guidewire 2082 may be left in place as shown in
As described herein with respect to
While various embodiments according to the present invention have been described above, it should be understood that they have been presented by way of illustration and example only, and not limitation. It will be apparent to persons skilled in the relevant art that various changes in form and detail can be made therein without departing from the spirit and scope of the invention. For example, catheter assemblies according to embodiments hereof may include a feature to limit or restrict the amount of relative longitudinal movement between the inner and outer shafts for properly positioning the support structure in the balloon. For example, a safe lock mechanism may be incorporated into a proximal handle of the device that controls the movement or sliding of the inner shaft relative to the outer shaft. In addition, stabilization mechanisms described herein may be utilized to anchor catheter assemblies within a subintimal space without inflation of the balloon. Rather, the balloon may function as an outer member that surrounds the self-expanding support structure to minimize damage to the anatomy. Thus, the breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the appended claims and their equivalents. It will also be understood that each feature of each embodiment discussed herein, and of each reference cited herein, can be used in combination with the features of any other embodiment. All patents and publications discussed herein are incorporated by reference herein in their entirety.
This application is a Division of and claims the benefit of U.S. patent application Ser. No. 14/197,803 filed Mar. 5, 2014, now allowed. The disclosures of which are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3568659 | Karnegia | Mar 1971 | A |
4552554 | Gould et al. | Nov 1985 | A |
4774949 | Fogarty | Oct 1988 | A |
5002532 | Graiser et al. | Mar 1991 | A |
5250069 | Nobuyoshi et al. | Oct 1993 | A |
5460608 | Lodin et al. | Oct 1995 | A |
5501667 | Verduin, Jr. | Mar 1996 | A |
5569184 | Crocker et al. | Oct 1996 | A |
5599324 | McAlister et al. | Feb 1997 | A |
5667493 | Janacek | Sep 1997 | A |
5707389 | Louw et al. | Jan 1998 | A |
5830222 | Makower | Nov 1998 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5947994 | Louw et al. | Sep 1999 | A |
6068638 | Makower | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6081738 | Hinohara et al. | Jun 2000 | A |
6159225 | Makower | Dec 2000 | A |
6178968 | Louw et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6196230 | Hall et al. | Mar 2001 | B1 |
6203524 | Burney et al. | Mar 2001 | B1 |
6210377 | Ouchi | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231563 | White et al. | May 2001 | B1 |
6231587 | Makower et al. | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6261260 | Maki et al. | Jul 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6375615 | Makower et al. | Apr 2002 | B1 |
6379319 | Garibotto et al. | Apr 2002 | B1 |
6432127 | Kim et al. | Aug 2002 | B1 |
6447477 | Burney et al. | Sep 2002 | B2 |
6458098 | Kanesaka | Oct 2002 | B1 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6514217 | Selmon et al. | Feb 2003 | B1 |
6514228 | Hamilton et al. | Feb 2003 | B1 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6579311 | Makower | Jun 2003 | B1 |
6602241 | Makower et al. | Aug 2003 | B2 |
6655386 | Makower et al. | Dec 2003 | B1 |
6669709 | Cohn et al. | Dec 2003 | B1 |
6709444 | Makower | Mar 2004 | B1 |
6719725 | Milo et al. | Apr 2004 | B2 |
6726677 | Makower et al. | Apr 2004 | B1 |
6746464 | Makower et al. | Jun 2004 | B1 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7059330 | Makower et al. | Jun 2006 | B1 |
7066914 | Andersen | Jun 2006 | B2 |
7141041 | Seward | Nov 2006 | B2 |
7179270 | Makower et al. | Feb 2007 | B2 |
7316655 | Garibotto et al. | Jan 2008 | B2 |
7357794 | Makower et al. | Apr 2008 | B2 |
7534223 | Boutilette et al. | May 2009 | B2 |
7606615 | Makower et al. | Oct 2009 | B2 |
7637870 | Flaherty et al. | Dec 2009 | B2 |
7729738 | Flaherty et al. | Jun 2010 | B2 |
7762985 | Kabrick et al. | Jul 2010 | B2 |
7833197 | Boutilette et al. | Nov 2010 | B2 |
7854727 | Belsley | Dec 2010 | B2 |
RE42049 | Schroeder et al. | Jan 2011 | E |
7878986 | Jen et al. | Feb 2011 | B2 |
7938819 | Kugler et al. | May 2011 | B2 |
8083727 | Kugler et al. | Dec 2011 | B2 |
8172863 | Robinson et al. | May 2012 | B2 |
8202246 | Kugler et al. | Jun 2012 | B2 |
8221357 | Boutillette | Jul 2012 | B2 |
8226566 | Nita | Jul 2012 | B2 |
8241311 | Ward et al. | Aug 2012 | B2 |
8257382 | Rottenberg et al. | Sep 2012 | B2 |
8323261 | Kugler et al. | Dec 2012 | B2 |
8337425 | Olson et al. | Dec 2012 | B2 |
8388876 | Boutilette et al. | Mar 2013 | B2 |
8460254 | Belsley | Jun 2013 | B2 |
8486022 | Ludwig et al. | Jul 2013 | B2 |
8496679 | Robinson et al. | Jul 2013 | B2 |
8512310 | Kugler et al. | Aug 2013 | B2 |
8535245 | Jen et al. | Sep 2013 | B2 |
8556857 | Boutillette | Oct 2013 | B2 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20020072706 | Hiblar et al. | Jun 2002 | A1 |
20030163154 | Miyata et al. | Aug 2003 | A1 |
20040073165 | Musbach et al. | Apr 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040186506 | Simpson et al. | Sep 2004 | A1 |
20050021003 | Caso et al. | Jan 2005 | A1 |
20050149062 | Carroll | Jul 2005 | A1 |
20050159728 | Armour et al. | Jul 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050267459 | Belhe et al. | Dec 2005 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060094930 | Sparks et al. | May 2006 | A1 |
20060241564 | Corcoran et al. | Oct 2006 | A1 |
20060276749 | Selmon et al. | Dec 2006 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080147000 | Seibel et al. | Jun 2008 | A1 |
20080249464 | Spencer et al. | Oct 2008 | A1 |
20090088685 | Kugler et al. | Apr 2009 | A1 |
20090124899 | Jacobs et al. | May 2009 | A1 |
20090192584 | Gerdts et al. | Jul 2009 | A1 |
20100010522 | Shturman | Jan 2010 | A1 |
20100063534 | Kugler et al. | Mar 2010 | A1 |
20110144677 | Ward et al. | Jun 2011 | A1 |
20110276079 | Kugler et al. | Nov 2011 | A1 |
20120053485 | Bloom | Mar 2012 | A1 |
20120095485 | Cully et al. | Apr 2012 | A1 |
20120283571 | Nita | Nov 2012 | A1 |
20120283761 | Rosenthal et al. | Nov 2012 | A1 |
20120323220 | Mackay, II et al. | Dec 2012 | A1 |
20120323251 | Kugler et al. | Dec 2012 | A1 |
20120323269 | Rottenberg et al. | Dec 2012 | A1 |
20130006167 | Alvarez | Jan 2013 | A1 |
20130006173 | Alvarez et al. | Jan 2013 | A1 |
20130006282 | Wilkinson | Jan 2013 | A1 |
20130072957 | Anderson | Mar 2013 | A1 |
20130103070 | Kugler et al. | Apr 2013 | A1 |
20130116622 | Takagi | May 2013 | A1 |
20130150880 | Anderson | Jun 2013 | A1 |
20130158519 | Boutilette et al. | Jun 2013 | A1 |
20130245430 | Selmon et al. | Sep 2013 | A1 |
20130261545 | Osypka | Oct 2013 | A1 |
20130296907 | Robinson et al. | Nov 2013 | A1 |
20130304108 | Weber et al. | Nov 2013 | A1 |
20130310868 | Kugler et al. | Nov 2013 | A1 |
20130317528 | Anderson et al. | Nov 2013 | A1 |
20140018732 | Bagaoisan et al. | Jan 2014 | A1 |
20140142607 | Cage | May 2014 | A1 |
20150174371 | Schaeffer et al. | Jun 2015 | A1 |
Number | Date | Country |
---|---|---|
1765193 | Oct 2012 | EP |
WO2008120209 | Oct 2008 | WO |
WO2009144561 | Dec 2009 | WO |
WO2013003757 | Jan 2013 | WO |
WO2013164825 | Nov 2013 | WO |
Entry |
---|
U.S. Appl. No. 13/952,973, filed Jul. 29, 2013, Silvestro. |
U.S. Appl. No. 13/952,981, filed Jul. 29, 2013, Silvestro. |
U.S. Appl. No. 14/058,444, filed Oct. 21, 2013, Silvestro. |
U.S. Appl. No. 14/460,048, filed Aug. 14, 2014, Guala et al. |
PCT/US2015/018148 The International Search Report and the Written Opinion of the International Searching Authority, dated Jun. 3, 2015. |
Shin et al. “Limitations of the Outback LTD re-entry device in femoropopliteal chronic total occlusions.” Journal of Vascular Surgery, vol. 53, 5; 2010. |
A. Bolia “Subintimial Angioplasty, the Way Forward” Acta chir belg, 2004, 104, 547-554. |
Karkos et al. “Subintimal Recanalization of the Femoropopliteal Segment to Promote Healing of an Ulcerated Below-Knee Amputation Stump” J Endovasc Ther 2006;13:420-423. |
Glasby et al. “Subintimal Angioplasty” Review, pp. 12-16, 2008. |
Bolia A. “Subintimal Angioplasty, Tips and Technique: How Long Can You Go?”. |
Number | Date | Country | |
---|---|---|---|
20160354096 A1 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14197803 | Mar 2014 | US |
Child | 15242871 | US |